Molecular mechanisms restoring olaparib efficacy through ATR/CHK1 pathway inhibition in olaparib-resistant BRCA1/2MUT ovarian cancer models. - Biegała Ł; Statkiewicz M; Gajek A; Szymczak-Pajor I; Rusetska N; Śliwińska A; Marczak A; Mikula M; Rogalska A (Biochimica et biophysica acta. Molecular basis of disease, 2025)